CREB3L2 Antibodies
We offer CREB3L2 Antibodies for use in common research applications: ELISA, Immunohistochemistry, Immunohistochemistry-Paraffin, Sandwich ELISA, Western Blot. Each CREB3L2 Antibody is fully covered by our Guarantee+, to give you complete peace of mind and the support when you need it. Our CREB3L2 Antibodies can be used in a variety of model species: Human. Use the list below to choose the CREB3L2 Antibody which is most appropriate for your research; you can click on each one to view full technical details, images, references, reviews and related products. Choose from our CREB3L2 polyclonal antibodies and browse our CREB3L2 monoclonal antibody catalog.
Alternate Names for CREB3L2 Antibodies
anti-CREB3L2 antibody, anti-B-ZIB transcription factor antibody, anti-basic transcription factor 2 antibody, anti-BBF2 human homolog on chromosome 7 antibody, anti-BBF2H7TCAG_1951439 antibody, anti-cAMP responsive element binding protein 3-like 2 antibody, anti-cAMP-responsive element-binding protein 3-like protein 2 antibody, anti-cyclic AMP-responsive element-binding protein 3-like protein 2 antibody, anti-FUS/BBF2H7 protein antibody, anti-MGC131709 antibody, anti-MGC71006 antibody
8 Results for "creb3l2" in Primary Antibodies
![Western Blot: CREB3L2 Antibody [NBP1-88697] - S1P inhibition induces autophagy and affects multiple UPR-related TFs. In vitro day 3 B-cells were treated with 10 uM PF-429242 or vehicle control (dH2O) for 72 h and were assessed for cell number using CountBright beads. Shown are the average cell numbers from 7 donors +/- standard deviations. Protein lysates generated from day 3 cells treated for 72 h with 10 uM PF-429242 were evaluated for CREB3L2 and ATF6 by Western blotting. Shown are representative results from 2 donors, a total of 7 donors were evaluated. Image collected and cropped by CiteAb from the following publication (//www.nature.com/articles/s41598-018-32705-7), licensed under a CC-BY license.](http://images.novusbio.com/fullsize/CREB3L2-Antibody-Western-Blot-NBP1-88697-img0008.jpg "<b>Biological Strategies Validation. </b>Western Blot: CREB3L2 Antibody [NBP1-88697] - S1P inhibition induces autophagy and affects multiple UPR-related TFs. In vitro day 3 B-cells were treated with 10 uM PF-429242 or vehicle control (dH2O) for 72 h and were assessed for cell number using CountBright beads. Shown are the average cell numbers from 7 donors +/- standard deviations. Protein lysates generated from day 3 cells treated for 72 h with 10 uM PF-429242 were evaluated for CREB3L2 and ATF6 by Western blotting. Shown are representative results from 2 donors, a total of 7 donors were evaluated. Image collected and cropped by CiteAb from the following publication (//www.nature.com/articles/s41598-018-32705-7), licensed under a CC-BY license.")
![<b>Biological Strategies Validation. </b>Immunohistochemistry-Paraffin: CREB3L2 Antibody [NBP1-88697] - Staining of human stomach shows moderate cytoplasmic positivity in glandular cells.](http://images.novusbio.com/fullsize/CREB3L2-Antibody-Immunohistochemistry-Paraffin-NBP1-88697-img0011.jpg)
![Western Blot: CREB3L2 Antibody [NBP1-88697] - Analysis in control (vector only transfected HEK293T lysate) and CREB3L2 over-expression lysate (Co-expressed with a C-terminal myc-DDK tag (3.1 kDa) in mammalian HEK293T cells).](http://images.novusbio.com/fullsize/CREB3L2-Antibody-Western-Blot-NBP1-88697-img0006.jpg)
![Western Blot: CREB3L2 Antibody [NBP1-88697] - Expression of CREB3L2 in differentiating primary human B-cells. Protein expression of CREB3L2 during in vitro differentiation of primary human B-cells. The day of culture is indicated at the top. Intact and dashed arrows show migration of full-length protein and cleaved C-terminus, respectively. Image collected and cropped by CiteAb from the following publication (//www.nature.com/articles/s41598-018-32705-7), licensed under a CC-BY license.](http://images.novusbio.com/fullsize/CREB3L2-Antibody-Western-Blot-NBP1-88697-img0007.jpg)
![Immunohistochemistry-Paraffin: CREB3L2 Antibody [NBP1-88697] - Staining of human placenta shows strong nuclear and cytoplasmic positivity in trophoblastic cells.](http://images.novusbio.com/fullsize/CREB3L2-Antibody-Immunohistochemistry-Paraffin-NBP1-88697-img0003.jpg)
![Immunohistochemistry-Paraffin: CREB3L2 Antibody [NBP1-88697] - Staining of human kidney shows strong cytoplasmci positivity in cells in tubules.](http://images.novusbio.com/fullsize/CREB3L2-Antibody-Immunohistochemistry-Paraffin-NBP1-88697-img0009.jpg)
![Immunohistochemistry-Paraffin: CREB3L2 Antibody [NBP1-88697] - Staining of human fallopian tube shows moderate cytoplasmic positivity in glandular cells.](http://images.novusbio.com/fullsize/CREB3L2-Antibody-Immunohistochemistry-Paraffin-NBP1-88697-img0010.jpg)
![Western Blot: CREB3L2 Antibody [NBP1-88697] - S1P inhibition induces autophagy & affects multiple UPR-related TFs. (A) In vitro day 3 B-cells were treated with 10 μM PF-429242 or vehicle control (dH2O) for 72 h & were assessed for cell number using CountBright beads. Shown are the average cell numbers from 7 donors ± standard deviations. Protein lysates generated from day 3 cells treated for 72 h with 10 μM PF-429242 were evaluated for (B) autophagy markers or (C) CREB3L2 & ATF6 by Western blotting. Shown are representative results from 2 donors, a total of 7 donors were evaluated. Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/30254311), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nbp1-88697_rabbit-polyclonal-creb3l2-antibody-310202415304281.jpg)
![Western Blot: CREB3L2 Antibody [NBP1-88697] - Kinetic & dose analysis of S1P-specific inhibitor PF-429242 during the early phase of ASC generation. (A) In vitro activated human B-cells were treated with 10 μM PF-429242 or vehicle control (dH2O) at day 3 & assessed for CREB3L2 processing at 12 h intervals. Representative results are shown from a total of 7 donors. (B) Samples from part (A) were assessed for cell number at the indicated time points. Displayed are the average cell number ± standard deviation derived from 7 donors. (C) In vitro activated human B-cells from 4 donors were treated with indicated amount PF-429242 or vehicle control (dH2O) at day 3 & assessed for cell number at 48 h. Results are displayed as the percentage viable cells relative to control. Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/30254311), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nbp1-88697_rabbit-polyclonal-creb3l2-antibody-310202415382439.jpg)
![Western Blot: CREB3L2 Antibody [NBP1-88697] - S1P-specific inhibitor PF-429242 blocks CREB3L2 processing. (A) Diagram of CREB3L2 structure with proteolytic cleavage sites. Act domain, Activation Domain. bZIP, Basic Leucine Zipper Domain. TM, Transmembrane Domain. (B) In vitro generated human ASCs were treated with 10 μM PF-429242 or vehicle control (dH2O) on the day that appears first (d6, d8, d10) & protein lysates generated on the day that appears subsequently (d8, d10, d13) were analyzed by Western blotting. Intact & dashed arrows show migration of CREB3L2 full-length protein & cleaved C-terminus, respectively. (C) In vitro differentiated human B-cells were treated with 10 μM PF-429242 or vehicle control (dH2O) at day 6 & analyzed subsequently for phenotype on the indicated days. Live cells were evaluated for expression of B-cell markers CD19 & CD20 & ASC markers CD38 & CD138. Percentages of cells are shown within the quadrant gates. The experiment was performed with 4 donors, a representative donor is shown. (D) Samples treated as in part (B) were assessed for cell number using CountBright beads. (E) In vitro activated human B-cells from 4 donors were treated with indicated amount PF-429242 or vehicle control (dH2O) at day 6 & assessed for cell number at 48 h. Results are displayed as the percentage viable cells relative to control. Supernatants from samples in part (B) were analyzed by ELISA for production of (F) IgM & (G) IgG. Significance was determined by t-test. Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/30254311), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nbp1-88697_rabbit-polyclonal-creb3l2-antibody-310202416121935.jpg)
![Western Blot: CREB3L2 Antibody [NBP2-87208] - Host: Rabbit. Target Name: CREB3L2. Sample Type: Human Fetal Muscle. Antibody Dilution: 1.0ug/ml](http://images.novusbio.com/fullsize/CREB3L2-Antibody-Western-Blot-NBP2-87208-img0005.jpg "Western Blot: CREB3L2 Antibody [NBP2-87208] - Host: Rabbit. Target Name: CREB3L2. Sample Type: Human Fetal Muscle. Antibody Dilution: 1.0ug/ml")
![Immunohistochemistry: CREB3L2 Antibody [NBP2-87208] - Human kidney](http://images.novusbio.com/fullsize/CREB3L2-Antibody-Immunohistochemistry-NBP2-87208-img0001.jpg)
![Western Blot: CREB3L2 Antibody [NBP2-87208] - WB Suggested Anti-CREB3L2 Antibody Titration: 1.25ug/ml. ELISA Titer: 1:12500. Positive Control: Jurkat cell lysate](http://images.novusbio.com/fullsize/CREB3L2-Antibody-Western-Blot-NBP2-87208-img0002.jpg)
![Western Blot: CREB3L2 Antibody [NBP2-87208] - Host: Rabbit. Target Name: CREB3L2. Sample Type: Human Fetal Brain. Antibody Dilution: 1.0ug/ml](http://images.novusbio.com/fullsize/CREB3L2-Antibody-Western-Blot-NBP2-87208-img0003.jpg)
![Western Blot: CREB3L2 Antibody [NBP2-87208] - Host: Rabbit. Target Name: CREB3L2. Sample Type: Human Fetal Heart. Antibody Dilution: 1.0ug/ml](http://images.novusbio.com/fullsize/CREB3L2-Antibody-Western-Blot-NBP2-87208-img0004.jpg)
![Immunocytochemistry/Immunofluorescence: CREB3L2 Antibody [NBP2-58761] - Staining of human cell line U-2 OS shows localization to nucleoplasm & endoplasmic reticulum. Antibody staining is shown in green.](http://images.novusbio.com/fullsize/CREB3L2-Antibody-Immunocytochemistry-Immunofluorescence-NBP2-58761-img0001.jpg "Immunocytochemistry/Immunofluorescence: CREB3L2 Antibody [NBP2-58761] - Staining of human cell line U-2 OS shows localization to nucleoplasm & endoplasmic reticulum. Antibody staining is shown in green.")
![Western Blot: CREB3L2 Antibody - BSA Free [NBP2-92030] - Western blot analysis of various lysates, using CREB3L2 Rabbit pAb at 1:2000 dilution.Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution.Lysates/proteins: 25ug per lane.Blocking buffer: 3% nonfat dry milk in TBST.Detection: ECL Basic Kit.Exposure time: 60s.](http://images.novusbio.com/fullsize/nbp2-92030_rabbit-polyclonal-creb3l2-antibody-422025142901.jpg%3Ft=1690971988 "Western Blot: CREB3L2 Antibody - BSA Free [NBP2-92030] - Western blot analysis of various lysates, using CREB3L2 Rabbit pAb at 1:2000 dilution.Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution.Lysates/proteins: 25ug per lane.Blocking buffer: 3% nonfat dry milk in TBST.Detection: ECL Basic Kit.Exposure time: 60s.")
![Western Blot: CREB3L2 Antibody [NBP2-87209] - Host: Rabbit. Target Name: CREB3L2. Sample Tissue: Human NCI-H226 Whole Cell lysates. Antibody Dilution: 1ug/ml](http://images.novusbio.com/fullsize/CREB3L2-Antibody-Western-Blot-NBP2-87209-img0001.jpg "Western Blot: CREB3L2 Antibody [NBP2-87209] - Host: Rabbit. Target Name: CREB3L2. Sample Tissue: Human NCI-H226 Whole Cell lysates. Antibody Dilution: 1ug/ml")
![Sandwich ELISA: CREB3L2 Antibody (1B8) [H00064764-M03] - Detection limit for recombinant GST tagged CREB3L2 is 0.1 ng/ml as a capture antibody.](http://images.novusbio.com/fullsize/CREB3L2-Antibody-1B8-Sandwich-ELISA-H00064764-M03-img0001.jpg "Sandwich ELISA: CREB3L2 Antibody (1B8) [H00064764-M03] - Detection limit for recombinant GST tagged CREB3L2 is 0.1 ng/ml as a capture antibody.")
![Immunohistochemistry-Paraffin: CREB3L2 Antibody [NBP2-97960] - Immunochemical staining of human CREB3L2 in human liver with rabbit polyclonal antibody at 1:100 dilution, formalin-fixed paraffin embedded sections.](http://images.novusbio.com/fullsize/CREB3L2-Antibody-Immunohistochemistry-Paraffin-NBP2-97960-img0001.jpg "Immunohistochemistry-Paraffin: CREB3L2 Antibody [NBP2-97960] - Immunochemical staining of human CREB3L2 in human liver with rabbit polyclonal antibody at 1:100 dilution, formalin-fixed paraffin embedded sections.")